Authors

• Sreenija Yarlagadda, Miami Cancer InstituteFollow
• Reshma Mahtani, Miami Cancer InstituteFollow
• Manmeet Ahluwalia, Miami Cancer InstituteFollow
• Rupesh Kotecha, Miami Cancer InstituteFollow

Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report

Publication Date

12-1-2025

Content Type

article

PubMed ID:

41026418

Additional Authors:

Additional Authors and Institutional Affiliations

Citation

Khatri, V. M., Mestres-Villanueva, M. A., Daniel, S., Yarlagadda, S., Doniparthi, A., Upadhyay, R., Mills, M. N., Oliver, D. E., Yu, H. M., Palmer, J. D., Stover, D. G., Williams, N. O., Mahtani, R. L., Ahluwalia, M. S., Soyano, A. E., Soliman, H. H., Han, H. S., Kotecha, R., Beyer, S. J., & Ahmed, K. A. (2025). Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report. Journal of neuro-oncology, 175(3), 1435–1441. https://doi.org/10.1007/s11060-025-05230-7